Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms
Tekijät
Päivämäärä
2023Tekijänoikeudet
© The Author(s)
Urinary tract infections (UTIs) are one of the most common bacterial infections in the world. The majority of UTIs are caused by uropathogenic E. coli (UPEC) which tend to live in surface-attached microbe communities, known as biofilms. Urinary tract infections can be cured with antibiotics, generally with good success. However, increased antibiotic resistance has led to a rise of recurrent UTIs and biofilms are in fact known to reduce the effect of antibiotics. One potential alternative to treat such infections in the future is phage therapy, i.e., using viruses that kill bacteria. The aim of this study was to find out how different bacteriophages (phages) can eliminate three different UPEC strains (EC7, EC10, EC38) growing in biofilms. Five different phages were produced for each strain. Biofilms of each strain were grown in the pegs of 96-well plate lids and then further treated with two different concentrations of phage lysates. In the experiment were studied not only the potential of individual phages, but also their combined effect in pairs and in a cocktail of five phages. The results were obtained by measuring the optical density at a wavelength of 600 nm every 30 minutes for 24 hours using Tecan Spark® microplate reader. The study shows that several treatments effectively reduce bacterial growth and thus, proves the potential of phage therapy as an effective novel approach. When the results are further consider together with a parallel antibiotic study, it is clear that phage therapy is a promising alternative for the treatment of bacterial infections, especially when combined with antibiotic treatment.
...
Asiasanat
Metadata
Näytä kaikki kuvailutiedotKokoelmat
- Pro gradu -tutkielmat [29545]
Lisenssi
Samankaltainen aineisto
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
-
Effects of Combined Use of Bacteriophages and Antibiotics to Eliminate Escherichia coli in Bacterial Biofilm
Valkonen, Sofia (2022)Antibiootit ovat yksi modernin historian menestyksekkäimmistä lääketieteellisistä löydöistä, ja niillä on ollut tärkeä rooli patogeenisten bakteerien aiheuttamien infektioiden torjunnassa. Vuosikymmeniä kestänyt antibioottien ... -
Characterization of Acinetobacter baumannii bacteriophages and determination of phage resistance costs in bacterial hosts
Ylänne, Matti (2021)Antibioottien teho on heikennyt maailmanlaajuisesti ja resistenssisyys monia eri antibiootteja vastaan on yleistynyt lähes kaikissa eri bakteerilajeissa. Acinetobacter baumannii on noussut esiin merkittävimpänä monen ... -
Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host
Mikonranta, Lauri; Buckling, Angus; Jalasvuori, Matti; Raymond, Ben (Royal Society Publishing, 2019)Phage therapy is attracting growing interest among clinicians as antibiotic resistance continues becoming harder to control. However, clinical trials and animal model studies on bacteriophage treatment are still scarce and ... -
Indirect Selection against Antibiotic Resistance via Specialized Plasmid-Dependent Bacteriophages
Penttinen, Reetta; Given, Cindy; Jalasvuori, Matti (MDPI AG, 2021)Antibiotic resistance genes of important Gram-negative bacterial pathogens are residing in mobile genetic elements such as conjugative plasmids. These elements rapidly disperse between cells when antibiotics are present ... -
Comparison of Delivery Methods in Phage Therapy against Flavobacterium columnare Infections in Rainbow Trout
Kunttu, Heidi M. T.; Runtuvuori-Salmela, Anniina; Middelboe, Mathias; Clark, Jason; Sundberg, Lotta-Riina (MDPI AG, 2021)Viruses of bacteria, bacteriophages, specifically infect their bacterial hosts with minimal effects on the surrounding microbiota. They have the potential to be used in the prevention and treatment of bacterial infections, ...
Ellei toisin mainittu, julkisesti saatavilla olevia JYX-metatietoja (poislukien tiivistelmät) saa vapaasti uudelleenkäyttää CC0-lisenssillä.